These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37183534)

  • 1. Assessment of abnormal placentation in pregnancies conceived with assisted reproductive technology.
    Violette CJ; Mandelbaum RS; Matsuzaki S; Ouzounian JG; Paulson RJ; Matsuo K
    Int J Gynaecol Obstet; 2023 Nov; 163(2):555-562. PubMed ID: 37183534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Number of Prior Cesareans and Early Preterm Delivery in Women with Abnormal Placentation.
    Oben A; Ausbeck EB; Gazi MN; Subramaniam A; Harper LM; Szychowski JM; Tita AT
    Am J Perinatol; 2021 Mar; 38(4):326-331. PubMed ID: 32992353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for placenta accreta spectrum: findings from the Japan environment and Children's study.
    Kyozuka H; Yamaguchi A; Suzuki D; Fujimori K; Hosoya M; Yasumura S; Yokoyama T; Sato A; Hashimoto K;
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):447. PubMed ID: 31775687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa.
    Melcer Y; Jauniaux E; Maymon S; Tsviban A; Pekar-Zlotin M; Betser M; Maymon R
    Am J Obstet Gynecol; 2018 Apr; 218(4):443.e1-443.e8. PubMed ID: 29353034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of abnormal placentation and hemorrhage in subsequent pregnancy following primary elective cesarean delivery.
    Chen S; Cheng W; Chen Y; Liu X
    J Matern Fetal Neonatal Med; 2020 Nov; 33(21):3608-3613. PubMed ID: 30741050
    [No Abstract]   [Full Text] [Related]  

  • 6. The association between uterine adenomyosis and adverse obstetric outcomes: A propensity score-matched analysis.
    Mandelbaum RS; Melville SJF; Violette CJ; Guner JZ; Doody KA; Matsuzaki S; Quinn MM; Ouzounian JG; Paulson RJ; Matsuo K
    Acta Obstet Gynecol Scand; 2023 Jul; 102(7):833-842. PubMed ID: 37087741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal placentation: evidence-based diagnosis and management of placenta previa, placenta accreta, and vasa previa.
    Rao KP; Belogolovkin V; Yankowitz J; Spinnato JA
    Obstet Gynecol Surv; 2012 Aug; 67(8):503-19. PubMed ID: 22926275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of placenta previa in pregnancies following IVF/ICSI; a comparison of ART and non-ART pregnancies in the same mother.
    Romundstad LB; Romundstad PR; Sunde A; von Düring V; Skjaerven R; Vatten LJ
    Hum Reprod; 2006 Sep; 21(9):2353-8. PubMed ID: 16728419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis.
    Jauniaux E; Bhide A
    Am J Obstet Gynecol; 2017 Jul; 217(1):27-36. PubMed ID: 28268196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta Accreta Spectrum: In Vitro Fertilization and Non-In Vitro Fertilization and Placenta Accreta Spectrum in a Massachusetts Cohort.
    Modest AM; Toth TL; Johnson KM; Shainker SA
    Am J Perinatol; 2021 Dec; 38(14):1533-1539. PubMed ID: 32623707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time trends in placenta-mediated pregnancy complications after assisted reproductive technology in the Nordic countries.
    Petersen SH; Bergh C; Gissler M; Åsvold BO; Romundstad LB; Tiitinen A; Spangmose AL; Pinborg A; Wennerholm UB; Henningsen AA; Opdahl S
    Am J Obstet Gynecol; 2020 Aug; 223(2):226.e1-226.e19. PubMed ID: 32109461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro fertilization as an independent risk factor for placenta accreta spectrum.
    Salmanian B; Fox KA; Arian SE; Erfani H; Clark SL; Aagaard KM; Detlefs SE; Aalipour S; Espinoza J; Nassr AA; Gibbons WE; Shamshirsaz AA; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2020 Oct; 223(4):568.e1-568.e5. PubMed ID: 32360847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta.
    Silver RM
    Obstet Gynecol; 2015 Sep; 126(3):654-668. PubMed ID: 26244528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assisted reproductive technology-associated risk factors for placenta accreta spectrum after vaginal delivery.
    Jwa SC; Tamaru S; Takamura M; Namba A; Kajihara T; Ishihara O; Kamei Y
    Sci Rep; 2024 Mar; 14(1):7454. PubMed ID: 38548810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis on placenta accreta spectrum disorders in twin pregnancies: risk factors, detection rate and histopathology.
    DI Girolamo R; Buca D; Galliani C; D'Amico A; CALì G; Lucidi A; Giannini C; Chiarelli F; Liberati M; D'Antonio F
    Minerva Obstet Gynecol; 2023 Feb; 75(1):55-61. PubMed ID: 34328297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrium-free uterine closure technique and abnormal placental implantation in subsequent pregnancies.
    Antoine C; Pimentel RN; Reece EA; Oh C
    J Matern Fetal Neonatal Med; 2021 Aug; 34(15):2513-2521. PubMed ID: 31581865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and clinical outcomes for placenta accreta spectrum with or without placenta previa.
    Ogawa K; Jwa SC; Morisaki N; Sago H
    Arch Gynecol Obstet; 2022 Mar; 305(3):607-615. PubMed ID: 34448037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologically diagnosed placenta accreta spectrum without placenta previa: a systematic review and meta-analysis.
    Sugai S; Yamawaki K; Sekizuka T; Haino K; Yoshihara K; Nishijima K
    Am J Obstet Gynecol MFM; 2023 Aug; 5(8):101027. PubMed ID: 37211089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Placenta Previa With Severe Maternal Morbidity Among Patients With Placenta Accreta Spectrum Disorder.
    Han X; Guo Z; Yang X; Yang H; Ma J
    JAMA Netw Open; 2022 Aug; 5(8):e2228002. PubMed ID: 35994286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal-occult placenta accreta: a clandestine source of maternal morbidity.
    Larish A; Horst K; Brunton J; Schenone M; Branda M; Mehta R; Packard A; VanBuren W; Norgan A; Shahi M; Missert A; Pompeian R; Greenwood J; Theiler R
    Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100924. PubMed ID: 36934974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.